Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 KO Manufacturing
Filings indexed 553 across all filing types
Latest filing 2024-09-09 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
전환가액의조정 (제38회차)
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price, the number of convertible shares, and the underlying methodology based on market price fluctuations. This type of disclosure regarding capital structure and debt-to-equity conversion terms falls under 'Capital/Financing Update'.
2024-09-09 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for HLB Co., Ltd. for the period ending June 30, 2024. It contains detailed company information, management history, capital structure, and business operations. As it is a comprehensive financial report for a period shorter than a full fiscal year (interim period) and includes substantive financial data and analysis, it is classified as an Interim/Quarterly Report. H1 2024
2024-08-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event, specifically a Non-Deal Roadshow (NDR) in Singapore and Hong Kong. It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2024-08-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document specifically details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of the major shareholder (Jin Yang-gon) and his special related parties in the company HLB. This type of filing is a mandatory disclosure for significant shareholding changes and does not fit into categories like Annual Reports, Earnings Releases, or Proxy Statements. It is a specific regulatory disclosure regarding ownership thresholds and major shareholding notifications.
2024-08-01 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (Non-Deal Roadshow). It provides details such as the date, location, purpose, and contact information for the event. Since it is an announcement of an event rather than the presentation materials themselves, and it fits the regulatory filing format for corporate event notifications, it is classified as a Regulatory Filing (RNS).
2024-07-22 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding the scheduling and details of an Investor Relations (IR) event (Corporate Day). It provides the date, time, location, and purpose of the meeting. Since it is an announcement of an upcoming event rather than the presentation slides themselves or a comprehensive financial report, it falls under the category of a regulatory filing announcement regarding corporate activities.
2024-07-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.